PD52-12 ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC)

Justin Shaya,J. Michael Randall,Frederick Millard,Razelle Kurzrock,J. Kellogg Parsons,Pablo Tamayo,Rana R. McKay

PD52-12 ANALYSIS OF THE PROGNOSTIC SIGNIFICANCE OF CIRCULATING TUMOR DNA (CTDNA) IN METASTATIC CASTRATE RESISTANT PROSTATE CANCER (MCRPC)

2020

Justin Shaya
J. Michael Randall
Frederick Millard
Razelle Kurzrock
J. Kellogg Parsons
Pablo Tamayo
Rana R. McKay

INTRODUCTION AND OBJECTIVE:Given the technical limitations of obtaining tissue next-generation sequencing, there has been considerable interest in blood ctDNA to assess genomic alterations in mCRPC...

Keywords:

Urology
Cancer research
Circulating tumor DNA
Castrate-resistant prostate cancer
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations